Mark Edward Montcalm, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 658 E Main St, Centreville, MI 49032 Phone: 269-467-3510 Fax: 269-467-3515 |
News Archive
Haematoma expansion, disability and death are common among patients who have intracerebral haemorrhage while taking novel oral anticoagulants, a study in JAMA Neurology shows.
The Sleep Research Society has selected three outstanding sleep and circadian scientists as recipients of the 2020 Sleep Research Society awards, which recognize excellence in sleep and circadian research.
Lawmakers across the United States continue to debate the safety of kratom, an opioid-containing plant that has been listed as a "drug of concern" by the U.S. Food and Drug Administration. Kratom is sold over the counter in specialty stores and online.
AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo
› Verified 2 days ago